Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback